Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

New insights into the cell lineage of pancreatic ductal adenocarcinoma: evidence for tumor stem cells in premalignant lesions?

Kopp JL, Sander M.

Gastroenterology. 2014 Jan;146(1):24-6. doi: 10.1053/j.gastro.2013.11.023. Epub 2013 Nov 22. No abstract available.

PMID:
24275238
2.

Insights into cell lineage of pancreatic adenocarcinoma.

Lowe AW, Moseley RH.

Gastroenterology. 2014 Jan;146(1):3-4. No abstract available.

PMID:
24501750
3.

Identification and manipulation of biliary metaplasia in pancreatic tumors.

Delgiorno KE, Hall JC, Takeuchi KK, Pan FC, Halbrook CJ, Washington MK, Olive KP, Spence JR, Sipos B, Wright CV, Wells JM, Crawford HC.

Gastroenterology. 2014 Jan;146(1):233-44.e5. doi: 10.1053/j.gastro.2013.08.053. Epub 2013 Aug 30.

4.

DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer.

Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R, Zhang H, Pasricha PJ, Bardeesy N, Matsui W, Maitra A, Leach SD.

Gastroenterology. 2014 Jan;146(1):245-56. doi: 10.1053/j.gastro.2013.09.050. Epub 2013 Oct 2.

5.

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I.

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

PMID:
21984419
6.

Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?

Klöppel G, Kosmahl M.

J Hepatol. 2006 Feb;44(2):249-50. Epub 2005 Dec 6. No abstract available.

PMID:
16360969
7.

[New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].

Esposito I, Konukiewitz B, Schlitter AM, Klöppel G.

Pathologe. 2012 Nov;33 Suppl 2:189-93. doi: 10.1007/s00292-012-1673-x. Review. German.

PMID:
23011021
8.

Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.

Shi G, DiRenzo D, Qu C, Barney D, Miley D, Konieczny SF.

Oncogene. 2013 Apr 11;32(15):1950-8. doi: 10.1038/onc.2012.210. Epub 2012 Jun 4.

9.
10.

Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage.

Carrière C, Young AL, Gunn JR, Longnecker DS, Korc M.

PLoS One. 2011;6(11):e27725. doi: 10.1371/journal.pone.0027725. Epub 2011 Nov 28.

11.

DeltaNp63 expression in pancreas and pancreatic neoplasia.

Basturk O, Khanani F, Sarkar F, Levi E, Cheng JD, Adsay NV.

Mod Pathol. 2005 Sep;18(9):1193-8.

12.

Where and when does pancreatic carcinoma start?

Lüttges J, Hahn S, Klöppel G.

Med Klin (Munich). 2004 Apr 15;99(4):191-5.

PMID:
15085289
13.
14.

Precancerous conditions of pancreatic carcinoma.

Lüttges J, Klöppel G.

J Hepatobiliary Pancreat Surg. 2000;7(6):568-74. Review.

PMID:
11180888
15.

A case of mistaken identity? Nonductal origins of pancreatic "ductal" cancers.

Murtaugh LC, Leach SD.

Cancer Cell. 2007 Mar;11(3):211-3.

16.

P53 expression in invasive pancreatic adenocarcinoma and precursor lesions.

Norfadzilah MY, Pailoor J, Retneswari M, Chinna K, Noor LM.

Malays J Pathol. 2011 Dec;33(2):89-94.

17.

[Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas].

Schlitter AM, Esposito I.

Chirurg. 2012 Feb;83(2):110-5. doi: 10.1007/s00104-011-2181-x. Review. German.

PMID:
22271052
18.

Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?

Rooman I, Real FX.

Gut. 2012 Mar;61(3):449-58. doi: 10.1136/gut.2010.235804. Epub 2011 Jul 5. Review.

PMID:
21730103
19.

MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.

Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P.

Am J Clin Pathol. 2002 May;117(5):791-6.

PMID:
12090430
20.

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H.

Clin Cancer Res. 2008 Nov 1;14(21):7043-9. doi: 10.1158/1078-0432.CCR-08-0381.

Supplemental Content

Support Center